Martin Mackay
Director · 2 filings · Latest: May 8, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Kailera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
CRL | Martin Mackay | Director | May 8, 2026 | Grant/Award | $177.62 | 2,845 | $505.3K | 17,137 |